comparemela.com
  1. Home
  2. Live Updates
  3. Recommending Trial Continue Without - Breaking News

Latest Breaking News On - Recommending trial continue without - Page 1 : comparemela.com

NeuroBo Pharmaceuticals Receives Safety Review Committee Approval to Continue With Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH

Blinded Safety Review Completed for the First 6 Months of the Phase 2a Clinical Trial Conduct; Recommending Trial Continue Without Modification Full Data Readout Expected in the Second Half of.

United kingdomMarshallh woodworthMichael millerNeurobo pharmaceuticals incPrnewswire neurobo pharmaceuticals incSafety review committeeDonga st coRx communications groupNeurobo pharmaceuticalsBlinded safety review completedClinical trial conductRecommending trial continue withoutData readout expectedSecond halfG protein coupled receptorHyung heon kim

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.